NCT00297401View on ClinicalTrials.gov

Renal and Peripheral Hemodynamic Function in Patients With Type 1 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

ruboxistaurin

32 mg, QD, PO, up to 8 weeks

DRUG

placebo

QD, PO, up to 8 weeks

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM - 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physcian., Toronto

All Listed Sponsors
collaborator

Heart and Stroke Foundation of Canada

OTHER

lead

Chromaderm, Inc.

INDUSTRY

NCT00297401 - Renal and Peripheral Hemodynamic Function in Patients With Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter